Page last updated: 2024-08-17

bromodeoxyuridine and Lymphoma, T Cell, Peripheral

bromodeoxyuridine has been researched along with Lymphoma, T Cell, Peripheral in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiba, K; Chiba, S; Enami, T; Furuta, J; Hasegawa, Y; Ishii, R; Ito, T; Izutsu, K; Kamada, Y; Komeno, T; Miyake, Y; Miyano, S; Muto, H; Nakamoto-Matsubara, R; Nakamura, N; Nanmoku, T; Noguchi, E; Noguchi, M; Nureki, O; Ogawa, S; Ohta, Y; Okuno, Y; Sakata, S; Sakata-Yanagimoto, M; Sanada, M; Sato, Y; Sato-Otsubo, A; Shimizu, S; Shiraishi, Y; Suzukawa, K; Takeuchi, K; Tanaka, H; Tran, NB; Tsuyama, N; Yoshida, K1

Other Studies

1 other study(ies) available for bromodeoxyuridine and Lymphoma, T Cell, Peripheral

ArticleYear
Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.
    Nature genetics, 2014, Volume: 46, Issue:2

    Topics: Animals; Base Sequence; Bromodeoxyuridine; Dioxygenases; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; DNA-Binding Proteins; Exome; Humans; Immunoblastic Lymphadenopathy; Isocitrate Dehydrogenase; Jurkat Cells; Lymphoma, T-Cell, Peripheral; Mice; Molecular Sequence Data; Mutation, Missense; NIH 3T3 Cells; Proto-Oncogene Proteins; rhoA GTP-Binding Protein; Sequence Analysis, DNA

2014